Should healthtech founders take grants or equity funding?

The answer depends on what you're trying to build and how fast you need to move.

Grants are cleanest on paper: no equity dilution, no repayment obligation, government funding designed to stimulate growth [#114]. But grants typically move slowly and come with strings attached to specific outcomes. Equity funding, by contrast, lets you move faster and brings capital partners who've scaled healthtech before.

The real tension sits elsewhere. Many founders instinctively resist giving away equity because they want to own their company [#105][#290]. That feeling often conflicts with building something at genuine scale. Some of the most successful tech-enabled healthcare businesses were built lean and weren't capital-intensive from the start [#357]. The founders who succeeded tended to be clear about how much capital they actually needed, rather than taking whatever was available. If your vision requires rapid execution and distribution muscle, equity makes sense. If your model works with constrained capital and long timelines, grants buy you runway without surrendering control. Neither is universally right; the trap is choosing based on ego rather than what your specific problem demands.